130 related articles for article (PubMed ID: 19853035)
1. Involvement of Dab1 in APP processing and beta-amyloid deposition in sporadic Creutzfeldt-Jakob patients.
Gavín R; Ferrer I; del Río JA
Neurobiol Dis; 2010 Feb; 37(2):324-9. PubMed ID: 19853035
[TBL] [Abstract][Full Text] [Related]
2. Fibrillar prion peptide PrP(106-126) treatment induces Dab1 phosphorylation and impairs APP processing and Abeta production in cortical neurons.
Gavín R; Ureña J; Rangel A; Pastrana MA; Requena JR; Soriano E; Aguzzi A; Del Río JA
Neurobiol Dis; 2008 May; 30(2):243-54. PubMed ID: 18374587
[TBL] [Abstract][Full Text] [Related]
3. Plaque-type deposition of prion protein in the damaged white matter of sporadic Creutzfeldt-Jakob disease MM1 patients.
Kobayashi A; Arima K; Ogawa M; Murata M; Fukuda T; Kitamoto T
Acta Neuropathol; 2008 Nov; 116(5):561-6. PubMed ID: 18751990
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical localization of 14.3.3 zeta protein in amyloid plaques in human spongiform encephalopathies.
Richard M; Biacabe AG; Streichenberger N; Ironside JW; Mohr M; Kopp N; Perret-Liaudet A
Acta Neuropathol; 2003 Mar; 105(3):296-302. PubMed ID: 12557018
[TBL] [Abstract][Full Text] [Related]
5. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
van Groen T; Kiliaan AJ; Kadish I
Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
[TBL] [Abstract][Full Text] [Related]
6. Association between deposition of beta-amyloid and pathological prion protein in sporadic Creutzfeldt-Jakob disease.
Debatin L; Streffer J; Geissen M; Matschke J; Aguzzi A; Glatzel M
Neurodegener Dis; 2008; 5(6):347-54. PubMed ID: 18349519
[TBL] [Abstract][Full Text] [Related]
7. Quantification of surviving cerebellar granule neurones and abnormal prion protein (PrPSc) deposition in sporadic Creutzfeldt-Jakob disease supports a pathogenic role for small PrPSc deposits common to the various molecular subtypes.
Faucheux BA; Morain E; Diouron V; Brandel JP; Salomon D; Sazdovitch V; Privat N; Laplanche JL; Hauw JJ; Haïk S
Neuropathol Appl Neurobiol; 2011 Aug; 37(5):500-12. PubMed ID: 21450052
[TBL] [Abstract][Full Text] [Related]
8. Cerebral amyloid angiopathy with co-localization of prion protein and beta-amyloid in an 85-year-old patient with sporadic Creutzfeldt-Jakob disease.
Paquet C; Privat N; Kaci R; Polivka M; Dupont O; Haïk S; Laplanche JL; Hauw JJ; Gray F
Acta Neuropathol; 2008 Nov; 116(5):567-73. PubMed ID: 18551298
[TBL] [Abstract][Full Text] [Related]
9. Redox metals and oxidative abnormalities in human prion diseases.
Petersen RB; Siedlak SL; Lee HG; Kim YS; Nunomura A; Tagliavini F; Ghetti B; Cras P; Moreira PI; Castellani RJ; Guentchev M; Budka H; Ironside JW; Gambetti P; Smith MA; Perry G
Acta Neuropathol; 2005 Sep; 110(3):232-8. PubMed ID: 16096758
[TBL] [Abstract][Full Text] [Related]
10. Prion protein (PrPc) promotes beta-amyloid plaque formation.
Schwarze-Eicker K; Keyvani K; Görtz N; Westaway D; Sachser N; Paulus W
Neurobiol Aging; 2005; 26(8):1177-82. PubMed ID: 15917101
[TBL] [Abstract][Full Text] [Related]
11. Creutzfeldt-Jakob disease associated with the R208H mutation in the prion protein gene.
Capellari S; Cardone F; Notari S; Schininà ME; Maras B; Sità D; Baruzzi A; Pocchiari M; Parchi P
Neurology; 2005 Mar; 64(5):905-7. PubMed ID: 15753435
[TBL] [Abstract][Full Text] [Related]
12. Games played by rogue proteins in prion disorders and Alzheimer's disease.
Aguzzi A; Haass C
Science; 2003 Oct; 302(5646):814-8. PubMed ID: 14593165
[TBL] [Abstract][Full Text] [Related]
13. Toluidine blue-O staining of prion protein deposits.
Sánchez A; Guzmán A; Ortiz A; Rembao D; Espinosa B; Zenteno E; Guevara J
Histochem Cell Biol; 2001 Dec; 116(6):519-24. PubMed ID: 11810193
[TBL] [Abstract][Full Text] [Related]
14. A traceback phenomenon can reveal the origin of prion infection.
Kobayashi A; Asano M; Mohri S; Kitamoto T
Neuropathology; 2009 Oct; 29(5):619-24. PubMed ID: 19659941
[TBL] [Abstract][Full Text] [Related]
15. Novel prion protein conformation and glycotype in Creutzfeldt-Jakob disease.
Zanusso G; Polo A; Farinazzo A; Nonno R; Cardone F; Di Bari M; Ferrari S; Principe S; Gelati M; Fasoli E; Fiorini M; Prelli F; Frangione B; Tridente G; Bentivoglio M; Giorgi A; Schininà ME; Maras B; Agrimi U; Rizzuto N; Pocchiari M; Monaco S
Arch Neurol; 2007 Apr; 64(4):595-9. PubMed ID: 17420324
[TBL] [Abstract][Full Text] [Related]
16. In vivo beta-secretase 1 inhibition leads to brain Abeta lowering and increased alpha-secretase processing of amyloid precursor protein without effect on neuregulin-1.
Sankaranarayanan S; Price EA; Wu G; Crouthamel MC; Shi XP; Tugusheva K; Tyler KX; Kahana J; Ellis J; Jin L; Steele T; Stachel S; Coburn C; Simon AJ
J Pharmacol Exp Ther; 2008 Mar; 324(3):957-69. PubMed ID: 18156464
[TBL] [Abstract][Full Text] [Related]
17. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects.
Parchi P; Giese A; Capellari S; Brown P; Schulz-Schaeffer W; Windl O; Zerr I; Budka H; Kopp N; Piccardo P; Poser S; Rojiani A; Streichemberger N; Julien J; Vital C; Ghetti B; Gambetti P; Kretzschmar H
Ann Neurol; 1999 Aug; 46(2):224-33. PubMed ID: 10443888
[TBL] [Abstract][Full Text] [Related]
18. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.
Hussain I; Hawkins J; Harrison D; Hille C; Wayne G; Cutler L; Buck T; Walter D; Demont E; Howes C; Naylor A; Jeffrey P; Gonzalez MI; Dingwall C; Michel A; Redshaw S; Davis JB
J Neurochem; 2007 Feb; 100(3):802-9. PubMed ID: 17156133
[TBL] [Abstract][Full Text] [Related]
19. Classification of sporadic Creutzfeldt-Jakob disease revisited.
Cali I; Castellani R; Yuan J; Al-Shekhlee A; Cohen ML; Xiao X; Moleres FJ; Parchi P; Zou WQ; Gambetti P
Brain; 2006 Sep; 129(Pt 9):2266-77. PubMed ID: 16923954
[TBL] [Abstract][Full Text] [Related]
20. Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice.
Tan J; Town T; Crawford F; Mori T; DelleDonne A; Crescentini R; Obregon D; Flavell RA; Mullan MJ
Nat Neurosci; 2002 Dec; 5(12):1288-93. PubMed ID: 12402041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
